Oncolytics Biotech (ONCY) Share-based Compensation (2009 - 2026)
Oncolytics Biotech (ONCY) posted Share-based Compensation of $3.47 million for FY2025, up 74.9% from $1.98 million in FY2024.
Powered by 
Analysis
Oncolytics Biotech (ONCY) Share-based Compensation (2009 - 2026) Analysis & Trends
Since FY2009, Oncolytics Biotech has reported Share-based Compensation for 17 years.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- The FY2025 figure stands as the highest annual Share-based Compensation in data going back to FY2009.
- Business Quant data shows ONCY's Share-based Compensation at $1.98 million in FY2024 (+39.5%), $1.42 million in FY2023 (-22.3%), $1.83 million in FY2022 (-40.1%) and $3.05 million in FY2021 (+59.8%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Oncolytics Biotech | 47.36 Mn | 23.68 Mn | - | 1.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.79 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Jun 30, 2025 | 362,000.00 |
| Mar 31, 2025 | 845,000.00 |
| Dec 31, 2024 | 856,155.57 |
| Sep 30, 2024 | 326,208.77 |
| Jun 30, 2024 | 369,957.12 |
| Mar 31, 2024 | 427,457.21 |
| Dec 31, 2023 | 557,512.47 |
| Sep 30, 2023 | 446,812.35 |
| Jun 30, 2023 | 180,157.50 |
| Mar 31, 2023 | 234,483.75 |
| Dec 31, 2022 | 551,790.50 |
| Sep 30, 2022 | 383,373.12 |
| Jun 30, 2022 | 384,413.98 |
| Mar 31, 2022 | 504,474.78 |
| Dec 31, 2021 | 895,487.62 |
| Sep 30, 2021 | 799,906.62 |
| Jun 30, 2021 | 839,756.90 |
| Mar 31, 2021 | 519,945.27 |
API Access
Oncolytics Biotech Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ONCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ONCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ONCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();